Clinical Trials Directory

Trials / Unknown

UnknownNCT04921293

Comparison Between Endogenous and Exogenous Ketosis in Patients With Non-ischemic Chronic Heart Failure With Reduced Ejection Fraction

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
18 (estimated)
Sponsor
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This randomized controlled trial will evaluate the effect of a ketogenic diet and/or exogenous administration of ketone bodies vs conventional diet on the ejection fraction of patients with non-ischemic chronic heart failure, measuring MRI biomarkers.

Detailed description

Evidence in both animals and humans suggests ketosis could be beneficial for people living with chronic heart failure. To date, no study has compared endogenous vs exogenous ketosis in patients with chronic heart failure. We will randomize (with a 1:1:1 ratio) patients with a confirmed diagnosis of non-ischemic chronic heart failure to undergo one of the following: 1. \- A ketogenic diet (\<50 gr of carbohydrates per day) incorporating current recommendations for heart failure (low sodium and liquids) for 10 days. 2. \- Standard diet incorporating current recommendations for heart failure (low sodium and liquids) and supplementation with exogenous ketones (ketone monoester) for 10 days. 3. \- Standard diet incorporating current recommendations for heart failure (low sodium and liquids) and supplementation with bitter taste placebo. The endpoints will be assessed using cardiac MRI and blood biomarkers.

Conditions

Interventions

TypeNameDescription
BEHAVIORALKetogenic dietA diet with \<50gr of carbohydrates per day. Monosaturated fats consumption will encourage over saturated fats
DIETARY_SUPPLEMENTExogenous ketonesAdministration of ketone monoester 25 ml t.i.d
BEHAVIORALStandard diet + placeboA standard diet incorporating current recommendations (low in sodium and low in liquids) for heart failure patients.

Timeline

Start date
2023-06-01
Primary completion
2024-10-20
Completion
2024-12-01
First posted
2021-06-10
Last updated
2022-10-18

Locations

1 site across 1 country: Mexico

Source: ClinicalTrials.gov record NCT04921293. Inclusion in this directory is not an endorsement.